InMode Ltd (INMD)

InMode Ltd. is a common stock listed on the NASDAQ exchange. The company develops, manufactures, and markets minimally invasive aesthetic medical devices built around its proprietary radio frequency-assisted lipolysis and deep subdermal fractional radiofrequency technologies. Its product range supports procedures such as liposuction with skin tightening, body and facial contouring, and ablative skin rejuvenation, and also includes applications in women’s health. InMode additionally markets non-invasive aesthetic systems used for permanent hair reduction, facial rejuvenation, wrinkle reduction, cellulite treatment, and the treatment of superficial benign vascular and pigmented lesions, along with hands-free products for skin tightening, fat reduction, and muscle stimulation. The company sells through distributors across the United States, Canada, Europe, Japan, Australia, and India. Incorporated in 2008 and based in Yokne'am, Israel, it was formerly known as Invasix Ltd. before adopting the InMode Ltd. name in November 2017.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.